AI-based fluid quantification in neovascular age-related macular degeneration and diabetic macular edema treated with faricimab – a real-life study
When AI-fluid volumetry is applied real-world nAMD and DME cases, then fluid volume offers a more sensitive and quantifiable measure of disease activity than CST.
Authors
- Warda Darwisch (ORCID: https://orcid.org/0000-0003-1980-4968)
- André Messias (ORCID: https://orcid.org/0000-0002-5328-9608)
- Boris V. Stanzel (ORCID: https://orcid.org/0000-0002-4316-1539)
- Karl Boden (ORCID: https://orcid.org/0000-0003-0277-2525)
- Anna Theresa Lorenz (ORCID: https://orcid.org/0009-0004-5945-1081)
- Philipp Ken Roberts
- Peter Szurman
Institutions
- Knappschaftsklinikum Saar (DE)
Publication Details
- Journal
- Graefe s Archive for Clinical and Experimental Ophthalmology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1007/s00417-025-06834-5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00